Skip to content

Clinical trials

Cholangiocarcinoma trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Country / region: Canada Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20143
20152
20161
20172
20182
201910
20205
20212
20224
20235
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated13
Completed12
Recruiting7
Active, not recruiting6
Enrolling by invitation1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto3
Jazz Pharmaceuticals2
Merck Sharp & Dohme LLC2
Symphogen A/S2
Taiho Oncology, Inc.2
AHS Cancer Control Alberta1
AbbVie1
Amgen1
AstraZeneca1
Basilea Pharmaceutica1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma41
Biliary Tract Neoplasms10
Stomach Neoplasms8
Bile Duct Neoplasms7
Esophageal Neoplasms7
Gallbladder Neoplasms7
Ovarian Neoplasms7
Carcinoma, Hepatocellular6
Colorectal Neoplasms6
Carcinoma, Non-Small-Cell Lung5

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.